|
Delayed
Bombay S.E.
02:01:21 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 161.30 INR | -2.86% |
|
-3.87% | +96.11% |
| Market Cap | 48.74B 511M 443M 415M 378M 712M 723M 4.89B 1.91B 24.4B 1.92B 1.88B 81.39B | P/E 2027 * |
22.1x | P/E 2028 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 48.74B 511M 443M 415M 378M 712M 723M 4.89B 1.91B 24.4B 1.92B 1.88B 81.39B | EV / Sales 2027 * |
1.78x | EV / Sales 2028 * | 1.55x |
| Free-Float |
33.91% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: IOL Chemicals and Pharmaceuticals Limited
| 1 day | -2.86% | ||
| 1 week | -3.87% | ||
| Current month | +10.33% | ||
| 1 month | -7.11% | ||
| 3 months | +47.53% | ||
| 6 months | +115.61% | ||
| Current year | +96.11% |
| 1 week | 155.8 | 178.5 | |
| 1 month | 143.55 | 179.65 | |
| Current year | 67.14 | 179.65 | |
| 1 year | 67.14 | 179.65 | |
| 3 years | 57.51 | 179.65 | |
| 5 years | 54.44 | 179.65 | |
| 10 years | 8.4 | 179.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 2019-11-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 2007-08-31 |
Vikas Gupta
BRD | Director/Board Member | 34 | 2015-05-28 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.86% | -3.87% | +75.04% | +117.01% | 511M | ||
| -0.92% | +1.43% | +83.05% | +128.86% | 1,078B | ||
| +0.47% | +1.98% | +50.26% | +50.75% | 632B | ||
| +0.83% | +2.85% | +24.49% | +64.82% | 443B | ||
| -0.88% | -0.66% | +45.09% | +36.64% | 356B | ||
| -0.37% | -1.15% | +26.89% | +36.31% | 289B | ||
| +0.05% | -1.20% | +2.31% | +6.15% | 245B | ||
| +0.40% | +3.21% | +44.42% | +59.17% | 226B | ||
| -0.42% | +1.58% | -8.48% | -51.94% | 204B | ||
| +1.67% | +5.56% | +14.98% | +72.68% | 171B | ||
| Average | -0.20% | +1.47% | +35.80% | +52.04% | 364.42B | |
| Weighted average by Cap. | -0.12% | +1.30% | +45.94% | +65.86% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 27.42B 287M 249M 233M 213M 401M 407M 2.75B 1.07B 13.73B 1.08B 1.06B 45.79B | 31.52B 330M 286M 268M 245M 460M 468M 3.16B 1.23B 15.78B 1.24B 1.21B 52.64B |
| Net income | 2.2B 23.03M 19.96M 18.71M 17.06M 32.11M 32.62M 220M 86.02M 1.1B 86.46M 84.59M 3.67B | 2.84B 29.76M 25.79M 24.18M 22.05M 41.48M 42.15M 285M 111M 1.42B 112M 109M 4.74B |
| Net Debt | - | - |
Employees
3,095
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | ₹161.30 | -2.86% | 89,289 |
| 26-08-13 | ₹166.05 | +4.93% | 159,958 |
| 26-08-12 | ₹158.25 | -3.21% | 140,071 |
| 26-08-11 | ₹163.50 | -0.88% | 304,677 |
| 26-08-10 | ₹164.95 | -1.70% | 566,578 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
166.05INR
Average target price
197.00INR
Spread / Average Target
+18.64%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions

















